Healthcare

Greybrook Health is a diversified Healthcare company that focuses on operating businesses in the medical device and healthcare service areas. Greybrook Health’s seasoned team of experienced professionals have been directly involved at the executive management level in creating billions of dollars of enterprise value for both private and public healthcare companies in North America.

With greater than two billion dollars of corporate finance transactions completed in the healthcare sector, our management team’s expertise in combination with our extensive network of cross border relationships provide Greybrook Health with a unique perspective and a major advantage in the Healthcare industry.

OUR PORTFOLIO

TMS NeuroHealth Inc.

TMS NeuroHealth is a subsidiary company of Greybrook Health that is focused on operating a network of mental health centers throughout North America that will provide repetitive transcranial magnetic stimulation therapy (TMS) for the treatment of major depressive disorder (MDD) and other neurological diseases.

TMS therapy is a safe, efficacious and virtually painless outpatient procedure that has no systemic side effects. It is a second line alternative to pharmacotherapy, of which approximately 50% of depression patients do not respond to.

» http://www.tms-n.com

Body Science M.D.

Body Science M.D. is a subsidiary company of Greybrook Health that is focused on operating a network of hormone balance and nutrition clinics throughout North America offering the best care to counter the effects of aging with bio-identical hormone replacement therapy (BHRT), nutrition counselling, and dermatological products and procedures

Through use of modern diagnostics, coupled with leading BHRT specialists, Body Science M.D. is focused on individually customized BHRT treatments and related products and supplements.

» http://www.bodysciencemd.com

Tearlab Corporation

NASDAQ:TEAR, TSX:TLB

TearLab Corporation, headquartered in San Diego, California, is commercializing a proprietary in vitro diagnostic tear testing platform, TearLab™, capable of accurately and rapidly measuring biomarkers in tears at the point-of-care.

TearLab Corporation is developing TearLab™ Osmolarity, a test intended to measure tear film osmolarity.

TearLab Corporation completed a merger with Occulogix Inc. in 2008. Occulogix Inc. went public in 2004 raising over 100 Million dollars to support its commercialization efforts.

» http://www.tearlab.com

MacuHealth

Macular Degeneration is a degenerative eye disease and the leading cause of blindness in people over the age of 50 in North America. Low Macular Pigment (MP) is a major risk factor for Macular Degeneration.

Macuhealth with LMZ3 is a patented nutritional supplement that contains the three pigments found in the macula. Regular intake of Macuhealth with LMZ3 has been shown to restore macular pigment to normal levels (up to 40% increase in MP over a 6 month period*)

» http://www.macuhealth.com

Kilmer Lucas Inc.

Kilmer Lucas is a leading investor relations and strategic advisory boutique. Working directly from our offices in New York, Toronto and San Francisco, and through a carefully assembled affiliate network that includes seasoned professionals based in Israel, Asia and Europe, we help our clients to successfully navigate and penetrate the capital markets and media both at home and abroad.

We are distinct in three important ways. First, we have been especially effective in leveraging our longstanding relationships and strong track record of success in the U.S. for the benefit of Israeli, Canadian and other non-U.S.-based companies. Second, in addition to providing a full range of traditional IR and PR services, we have developed particular expertise in IR 2.0 — offering innovative social media strategies, programs and tools that are Reg FD compliant. Third, all strategic and day-to-day client program management is provided by senior practitioners – each possessing a minimum of 15 years of direct experience gained outside of an agency environment.

» http://www.kilmerlucas.com

BioTuesday Publishing Corporation

BioTuesdays.com is a popular healthcare business and investing news blog. When it was launched in 2009, one thing was crystal clear – ever since Leonard Zehr retired from The Globe and Mail, there had been a noticeable void of traditional Canadian business media coverage of all but the very largest healthcare issuers. Looking south, we noticed the same thing. If a company’s stock price and/or market cap were below a certain threshold, US media outlets just wouldn’t (or in many cases, couldn’t) pay them any attention.

So, BioTuesdays.com was created to change that. Our goal is to give great, but not necessarily big or well known, healthcare companies and their stories the exposure that they deserve.

» http://www.biotuesdays.com